These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 18760805

  • 1. Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis.
    Ren CL, Pasta DJ, Rasouliyan L, Wagener JS, Konstan MW, Morgan WJ, Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    J Pediatr; 2008 Dec; 153(6):746-51. PubMed ID: 18760805
    [Abstract] [Full Text] [Related]

  • 2. Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis.
    De Boeck K, Vermeulen F, Wanyama S, Thomas M, members of the Belgian CF Registry.
    Eur Respir J; 2011 May; 37(5):1091-5. PubMed ID: 21071470
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
    Zemel BS, Jawad AF, FitzSimmons S, Stallings VA.
    J Pediatr; 2000 Sep; 137(3):374-80. PubMed ID: 10969263
    [Abstract] [Full Text] [Related]

  • 4. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex.
    Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NH, Timens W, Postma DS.
    Thorax; 2006 Feb; 61(2):105-10. PubMed ID: 16308336
    [Abstract] [Full Text] [Related]

  • 5. Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE.
    de Marco R, Marcon A, Jarvis D, Accordini S, Bugiani M, Cazzoletti L, Cerveri I, Corsico A, Gislason D, Gulsvik A, Jõgi R, Martínez-Moratalla J, Pin I, Janson C, ECRHS Therapy Group.
    J Allergy Clin Immunol; 2007 Mar; 119(3):611-7. PubMed ID: 17258304
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
    Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA, Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
    [Abstract] [Full Text] [Related]

  • 7. Use of high-dose ibuprofen in a pediatric cystic fibrosis center.
    Fennell PB, Quante J, Wilson K, Boyle M, Strunk R, Ferkol T.
    J Cyst Fibros; 2007 Apr; 6(2):153-8. PubMed ID: 16844429
    [Abstract] [Full Text] [Related]

  • 8. High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial.
    Lands LC, Milner R, Cantin AM, Manson D, Corey M.
    J Pediatr; 2007 Sep; 151(3):249-54. PubMed ID: 17719932
    [Abstract] [Full Text] [Related]

  • 9. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use.
    McPhail GL, Acton JD, Fenchel MC, Amin RS, Seid M.
    J Pediatr; 2008 Dec; 153(6):752-7. PubMed ID: 18760423
    [Abstract] [Full Text] [Related]

  • 10. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.
    Amadori A, Antonelli A, Balteri I, Schreiber A, Bugiani M, De Rose V.
    Respir Med; 2009 Mar; 103(3):407-13. PubMed ID: 19027279
    [Abstract] [Full Text] [Related]

  • 11. Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis.
    Konstan MW, Schluchter MD, Xue W, Davis PB.
    Am J Respir Crit Care Med; 2007 Dec 01; 176(11):1084-9. PubMed ID: 17872492
    [Abstract] [Full Text] [Related]

  • 12. Treatment of airway inflammation in cystic fibrosis.
    Konstan MW.
    Curr Opin Pulm Med; 1996 Nov 01; 2(6):452-6. PubMed ID: 9363184
    [Abstract] [Full Text] [Related]

  • 13. Anti-inflammatory therapy in cystic fibrosis.
    Dinwiddie R.
    J Cyst Fibros; 2005 Aug 01; 4 Suppl 2():45-8. PubMed ID: 16005266
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease.
    Murphy TD, Anbar RD, Lester LA, Nasr SZ, Nickerson B, VanDevanter DR, Colin AA.
    Pediatr Pulmonol; 2004 Oct 01; 38(4):314-20. PubMed ID: 15334509
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function.
    Bastardo CM, Sonnappa S, Stanojevic S, Navarro A, Lopez PM, Jaffe A, Bush A.
    Thorax; 2009 Mar 01; 64(3):246-51. PubMed ID: 19052050
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.